experiencing COVID symptoms which included cough and runny nose but no fever/ Covid-19,still tested positive today; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (experiencing COVID symptoms which included cough and runny nose but no fever/ Covid-19,still tested positive today) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter and second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 09-May-2022, the patient experienced COVID-19 (experiencing COVID symptoms which included cough and runny nose but no fever/ Covid-19,still tested positive today). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (experiencing COVID symptoms which included cough and runny nose but no fever/ Covid-19,still tested positive today) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) COVID-19 positive.         No Concomitant medication reported.  Paitent experienced COVID symptoms which included cough and runny nose and cold like symptoms. It was reported that patient had been double vaccinated and boosted with Moderna had a breakthrough of an unknown variant. Paitent had tested positive with the home antigen test and was mildly symptomatic.  No Treatment medication reported.  Company Comment: This spontaneous case concerns a female patient of unknown age with no relevant medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with positive SARS-CoV-2 Antigen Test) which occurred on unknown days after receiving the third dose of mRNA-1273 vaccine. Patient also received mRNA-1273 vaccine for the primary series of COVID-19 vaccination however the dates of administration was not provided. Patient developed mild symptoms of cough and rhinorrhea.  An antigen test for SARS-CoV-2 was performed and revealed positive result. She was treated with unspecified dose of Nirmatrelvir/Ritonavir (Paxlovid). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a female patient of unknown age with no relevant medical history who experienced the unexpected, non-serious adverse event of special interest of COVID-19 (with positive SARS-CoV-2 Antigen Test) which occurred on unknown days after receiving the third dose of mRNA-1273 vaccine. Patient also received mRNA-1273 vaccine for the primary series of COVID-19 vaccination however the dates of administration was not provided. Patient developed mild symptoms of cough and rhinorrhea.  An antigen test for SARS-CoV-2 was performed and revealed positive result. She was treated with unspecified dose of Nirmatrelvir/Ritonavir (Paxlovid). The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.